MOONLAKE IMMUNOTHERAPEUTICS
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Sep 2020 | — | $20.0K | — |
| Dec 2020 | — | $-2.5M | $1.3M |
| Mar 2021 | — | $106.5K | $0 |
| Mar 2021 | — | $106.5K | — |
| Mar 2021 | — | $-2.6M | $1.2M |
| Jun 2021 | — | $5.0M | $1.1M |
| Sep 2021 | — | $-4.8M | $1.0M |
| Dec 2021 | — | $-11.6M | $8.0M |
| Mar 2022 | — | $24.4M | $23.3K |
| Jun 2022 | — | $63.5M | $92.7M |
| Sep 2022 | — | $55.3M | $41.2M |
| Dec 2022 | — | $48.9M | $39.5M |
| Mar 2023 | — | $42.0M | $50.1M |
| Jun 2023 | — | $489.8M | $501.8M |
| Sep 2023 | — | $424.9M | $318.2M |
| Dec 2023 | — | $495.7M | $451.2M |
| Mar 2024 | — | $542.6M | $458.4M |
| Jun 2024 | — | $520.7M | $342.8M |
| Sep 2024 | — | $488.2M | $375.7M |
| Dec 2024 | $0 | $446.8M | $180.4M |
| Mar 2025 | $73.0M | $407.5M | $271.6M |
| Jun 2025 | $73.4M | $353.7M | $306.7M |
| Sep 2025 | $73.7M | $288.9M | $350.7M |
| Dec 2025 | $74.1M | $304.5M | $334.5M |
| Mar 2026 | $99.0M | $254.0M | $298.5M |
| Jun 2026 | $99.5M | $428.2M | $477.9M |